Smith, Kline & French
E495721
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
All labels observed (2)
| Label | Occurrences |
|---|---|
| SmithKline | 2 |
| Smith, Kline & French canonical | 1 |
Statements (32)
| Predicate | Object |
|---|---|
| instanceOf |
defunct company
ⓘ
pharmaceutical company ⓘ |
| activity |
clinical development
ⓘ
drug discovery ⓘ pharmaceutical marketing ⓘ |
| businessModel | research-based pharmaceutical company ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| eventualParentCompany | GlaxoSmithKline NERFINISHED ⓘ |
| field |
drug development
ⓘ
medical research ⓘ pharmacology ⓘ |
| hasSuccessorOrganization |
GlaxoSmithKline
NERFINISHED
ⓘ
SmithKline Beckman NERFINISHED ⓘ SmithKline Beecham NERFINISHED ⓘ |
| industry | pharmaceutical industry ⓘ |
| knownFor |
development of important prescription drugs
ⓘ
marketing of important prescription drugs ⓘ research in gastrointestinal drugs ⓘ research in psychopharmacology ⓘ |
| market | global prescription drug market ⓘ |
| mergedInto |
SmithKline Beckman
NERFINISHED
ⓘ
SmithKline Beecham NERFINISHED ⓘ |
| notableProduct |
Tagamet
NERFINISHED
ⓘ
Thorazine NERFINISHED ⓘ |
| partOf | SmithKline Beecham NERFINISHED ⓘ |
| productType |
pharmaceutical preparations
ⓘ
prescription drugs ⓘ |
| sector | healthcare ⓘ |
| status | defunct ⓘ |
| successor | GlaxoSmithKline NERFINISHED ⓘ |
| timePeriod | 20th century ⓘ |
| typeOfCompany | public company ⓘ |
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
SmithKline
this entity surface form:
SmithKline